Seemax Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1560.84%
(FY 2023)
- Profit 638.79%
(FY 2023)
- Ebitda 324.59%
(FY 2023)
- Net Worth 368.86%
(FY 2023)
- Total Assets 537.06%
(FY 2023)
About Seemax Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitish Jha and Seema Jha serve as directors at the Company.
- CIN/LLPIN
U24230UP2020PTC129059
- Company No.
129059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Seemax Biotech Private Limited offer?
Seemax Biotech Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Physiotherapy Equipment, Hospital & Medical Lights, Examination Lights, Surgical & ICU Equipments, Pulse Oximeter, Glucometer & POCT Devices, Orthopedic Equipment & Supplies, Orthopedic Trauma Implants, Orthopedic Instruments, Traction Equipment.
Who are the key members and board of directors at Seemax Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitish Jha  | Director | 03-Jun-2020 | Current |
| Seema Jha | Director | 03-Jun-2020 | Current |
Financial Performance of Seemax Biotech.
Seemax Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1560.84% increase. The company also saw a substantial improvement in profitability, with a 638.79% increase in profit. The company's net worth Soared by an impressive increase of 368.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seemax Biotech?
Unlock access to Seemax Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Seemax Biotech?
Unlock and access historical data on people associated with Seemax Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seemax Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seemax Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
